The itchy locus encodes a novel ubiquitin protein ligase that is disrupted in a(18H) mice

Nature Genetics

Volumn 18, Issue 2, 1998, Pages 143-146

  Perry, William L ^a,b   Hustad, Carolyn M ^a   Swing, Debra A ^a   Norene O'Sullivan, T ^a   Jenkins, Nancy A ^a   Copeland, Neal G ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Utah   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

UBIQUITIN PROTEIN LIGASE;

ARTICLE; CELL GROWTH; GENE CONTROL; GENE LOCUS; GENE MUTATION; GENE STRUCTURE; HEMATOPOIETIC CELL; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION;

EID: 0031915677     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/ng0298-143     Document Type: Article

References (25)

1. Hustad, C.M. et al. Molecular genetic characterization of six recessive viable alleles of the mouse agouti locus. Genetics 140, 255-265 (1995).
2. Church, D.M. et al. Isolation of genes from complex sources of mammalian genomic DNA using exon amplification. Nature Genet. 6, 98-105 (1994).
3. Scheffner, M., Nuber, U. & Huibregtse, J.M. Protein ubiquitination involving an E1-E2-E3 enzyme ubiquitin thioester cascade. Nature 375, 81-83 (1995).
4. Kozak, M. An analysis of 5′-noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res. 15, 8125-8148 (1987).
5. Huibregtse, J.M., Scheffner, M. & Howley, P.M. Cloning and expression of the cDNA for E6-Ap, a protein that mediates the interaction of the human papillomavirus E6 oncoprotein with p53. Mol. Cell. Biol. 13, 775-784 (1993).
6. Huibregtse, J.M., Scheffner, M., Beaudenon, S. & Howley, P.M. A family of proteins structurally and functionally related to the E6-AP ubiquitin-protein ligase. Proc. Natl. Acad. Sci. USA 92, 2563-2567 (1995).
7. Sudol, M. The WW module competes with the SH3 domain? Trends Biochem. Sci. 21, 161-163 (1996).
8. 2+/phospholipid binding. J. Biol. Chem. 268, 26386-26390 (1993).
9. Vrieling, H.D., Duhl, M.J., Millar, S.E., Miller, K.A. & Barsh, G.S. Differences in dorsal and ventral pigmentation results from regional expression of the mouse agouti gene. Proc. Natl. Acad. Sci. USA 91, 170-178 (1994).
10. Green, M.C. & Schultz, L.D. Motheaten, an immunodeficient mutant of the mouse. I. Genetics and pathology. J. Hered. 66, 250-258 (1975).
11. Sidman, C.L., Shultz, L.D. & Unanue, E.R. The mouse mutant "motheaten." I. Development of lymphocyte populations. J. Immunol. 121, 2392-2398 (1978).
12. Ward, J.M. Pulmonary pathology of the motheaten mouse. Vet. Pathol. 15, 170-178 (1978).
13. Shultz, L.D. et al. Mutations at the murine motheaten locus are within the haematopoietic cell protein-tyrosine phosphatase (Hcph) gene. Cell 73, 1445-1454 (1993).
14. Tsui, H.W., Siminovitch, K.A., De Souza, L. & Tsui, F.W.L. Motheaten and viable motheaten mice have mutations in the haematopoietic cell phosphatase gene. Nature Genet. 4, 124-129 (1993).
15. Jiao, H. et al. Macrophages from motheaten and viable motheaten mutant mice show increased proliferative responses to GM-CSF: Detection of potential HCP substrates in GM-CSF signal transduction. Exp. Haematol. 25, 532-600 (1997).
16. Piao, X., Paulson, R., van der Geer, P., Pawson, T. & Bernstein, A. Oncogenic mutation in the Kit receptor tyrosine kinase alters substrate specificity and induces degradation of the protein tyrosine phosphatase SHP-1. Proc. Natl. Acad. Sci. USA 93, 14665-14669 (1996).
17. David, M., Chen, H.E., Goelz, S., Larner, A.C. & Neel, B.G. Differential regulation of the alpha/beta interferon-stimulated Jak/Stat pathway by the SH2 domain-containing tyrosine phosphatase SHPTP1. Mol. Cell. Biol. 15, 7050-7058 (1995).
18. Lee, F.S., Hagler, J., Chen, Z.J. & Maniatis, T. Activation of the IkappaB alpha kinase complex by MEKK1, a kinase of the JNK pathway. Cell 88, 213-222 (1997).
19. Miyazawa, K. et al. Ligand-dependent polyubiquitination of c-kit gene product: a possible mechanism of receptor down modulation in M107e cells. Blood 83, 137-145 (1994).
20. Mori, S., Heldin, C.-H. & Claesson-Welsh, L. Ligand-induced polyubiquitination of the platelet-derived growth factor β-receptor plays a negative regulatory role in its mitogenic signaling. J. Biol. Chem. 268, 577-583 (1992).
21. Mori, S., Claesson-Welsh, L. Okuyama, Y. & Saito, Y. Ligand-induced polyubiquitination of receptor tyrosine kinases. Biochem. Biophys. Rec. Comm. 213, 32-39 (1995).
22. Mori, S., Tanaka, K., Omura, S. & Saito, Y. Degradation process of ligand-stimulated platelet-derived growth factor receptor involves ubiquitin-proteasome proteolytic pathway. J. Biol. Chem. 270, 29447-29452 (1995).
23. Cattanach, B.M., Lyon, M.F., Peters, J. & Searle, A.G. Agouti locus mutations at Harwell. Mouse News Lett. 77, 123-125 (1987).
24. Gish, W. & States, D.J. Identification of protein coding regions by database similarity search. Nature Genet. 3, 266-272 (1993).
25. Perry, W.L., Hustad, C.M., Swing, D.A., Jenkins, N.A. & Copeland, N.G. A transgenic mouse assay for agouti protein activity. Genetics 140, 267-274 (1995).